Terry Novak has forty years of pharmaceutical, biotech and CDMO business development, marketing, operations, C-suite executive, and board oversight experience. Terry has served on numerous Boards of Directors, such as Salubrent Pharma Solutions, Pernix Therapeutics Ireland, Percivia LLC, American Red Cross Northern NJ Division, Patheon Puerto Rico, Frontline Pharmaceuticals, and Curaxis Pharmaceutical. After spending 15 years at Bristol Myers Squibb in sales and senior sales management, Terry entered the contract service sector. Terry’s diverse CDMO experience includes API, oral solid dose and sterile fill-finish development and manufacturing. Currently he serves as the COO of Bright Path Labs, a technology-focused continuous flow API provider. Previous positions include, CEO of Tedor Pharmaceuticals, COO of Pernix Pharma, President of Norwich Pharmaceuticals, President of Patheon North America, and the President of DSM Pharmaceutical Products.
Terry is originally from Allentown, PA where he graduated from Muhlenberg College. Most of his career was spent in New Jersey and North Carolina where he now resides in Charlotte, NC. During his career he traveled extensively throughout Europe and Japan.
During the last ten years, Terry has been focused on early stage CDMOs that need extensive business and operational revamping. Terry has developed a reputation in the CDMO sector as a turnaround specialist and a superior operator focused on strategic growth through operational excellence. His track record of rapid turn-around success includes achieving consistent double-digit growth in revenues and EBITDA by leveraging lifelong relationships in the industry and successfully executing targeted operational, sales and marketing plans. Terry possesses and maintains high level relationships across the sector with key decision-makers at pharma and biotech companies throughout the world. Over his career he has managed P&Ls up to $250MM and spearheaded due diligence and contract negotiations resulting in over $800MM in acquisitions and contract service agreements.
Terry serves on the North Carolina Biotech Association Advisory Board.
